Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|September 3, 2025
A Practical Approach to the Diagnosis and Management of Hepatic EncephalopathyNancy Reau, David Bernstein, Paul Kwo, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2022
Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis-related hospitalisations in the USAshwani K Singal, Yong-Fang Kuo, K Rajender Reddy, et al.
Transplantation|June 8, 2015
Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted PatientsMarwan Ghabril, Saurabh Agarwal, Marco Lacerda, et al.
Journal of Translational Medicine|November 7, 2008
Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatmentMilton W Taylor, Takuma Tsukahara, Jeanette N McClintick, et al.
Abdominal Radiology (New York)|February 6, 2016
Risk factors for bleeding after liver biopsyKumaresan Sandrasegaran, Nilasha Thayalan, Raghavi Thavanesan, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2026
Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD MedicationsAmir Gougol, Paul Kwo, William Pike, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|November 19, 2025
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: Are We Doing Enough?Sun H Kim, Gavin Hui, C William Pike, et al.
Clinical Transplantation|May 11, 2022
Impact of medical eligibility criteria and OPTN policy on simultaneous liver kidney allocation and utilizationAshwani K Singal, Yong-Fang Kuo, Paul Kwo, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
OCE-205, a selective V1a receptor mixed agonist-antagonist, for the treatment of hepatorenal syndrome-acute kidney injury: A phase 2 randomized trialAndrew S Allegretti, Giuseppe Cullaro, Paul Kwo, et al.
Transplantation|November 13, 2023
Use and Outcomes of Hepatitis B Virus-positive Grafts for Kidney or Heart Transplantation in the United States From 1999 to 2021Ashwani K Singal, K Rajender Reddy, Mindie H Nguyen, et al.
Pageof 7